Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled… Grant US-11633502-B2 United States of America 25 Apr 2023
METHODS AND COMPOSITIONS RELATING TO IMPROVED COMBINATION THERAPIES Application WO-2021183318-A2 World Intellectual Property Organisation (WIPO) 16 Sep 2021
Compositions and methods of treating therapy resistant cancer and uses thereof Grant US-10842749-B2 United States of America 24 Nov 2020
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions Grant US-10328130-B2 United States of America 25 Jun 2019
Pharmaceutical formulations of ecteinascidin compounds Grant US-10322183-B2 United States of America 18 Jun 2019
Combination therapy with an anti-hyaluronan agent and therapeutic agent Grant US-10137104-B2 United States of America 27 Nov 2018
Combination therapy with an anti-hyaluronan agent and therapeutic agent Grant US-9913822-B2 United States of America 13 Mar 2018
Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof… Grant US-9333244-B2 United States of America 10 May 2016
COMPOSITIONS AND METHODS FOR TARGETED IN VITRO AND IN VIVO DRUG DELIVERY TO MAMMALIAN… Application EP-2992901-A1 European Patent Office 09 Mar 2016
Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related… Grant US-9192568-B2 United States of America 24 Nov 2015
Particulate drug carriers as desensitizing agents Grant US-9078812-B2 United States of America 14 Jul 2015
Cellulose-based nanoparticles for drug delivery Grant US-8591877-B2 United States of America 26 Nov 2013
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and… Grant US-8431380-B2 United States of America 30 Apr 2013
LIPOSOMES COMPRISING AMPHIPATHIC DRUGS AND METHOD FOR THEIR PREPARATION Application WO-2011092708-A2 World Intellectual Property Organisation (WIPO) 04 Aug 2011